Biopharma Acquisitions Biopharma merger and acquisition value for the third quarter of 2022 reached $15.4bn from 41 transactions, 21 of which had disclosed values. Four M&A transactions hit or exceede
IN VITRO DIAGNOSTICS Mergers & Acquisitions Clinical Genomics Technologies Pty. Ltd. Quest Diagnostics Inc. Enterix Inc. As part of a continued effort to focus on its Diagnostics Information Services
IN VITRO DIAGNOSTICS Mergers & Acquisitions Analytik Jena AG SIRS-Lab GMBH Life sciences firm Analytik Jena AG has acquired all of the assets of insolvent molecular diagnostics firm SIRS-Lab GMB